Black Rock Inc. Nektar Therapeutics Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NKTR
# of Institutions
96Shares Held
83.7MCall Options Held
1.18MPut Options Held
64.6K-
Nantahala Capital Management, LLC New Canaan, CT7.79MShares$184 Million0.24% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$157 Million0.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.7MShares$111 Million0.01% of portfolio
-
Almitas Capital LLC Santa Monica, CA4.61MShares$109 Million1.77% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4MShares$94.4 Million0.66% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $4.42B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...